Maco Pharma International GmbH
Maco Pharma International GmbH, a leading name in the medical technology sector, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 1985, the company has established itself as a key player in the development and manufacturing of innovative solutions for blood and cell therapies, as well as transfusion medicine. Maco Pharma's core offerings include a range of medical devices and consumables designed to enhance the safety and efficiency of blood management processes. Their commitment to quality and innovation has positioned them as a trusted partner in healthcare, with notable achievements in regulatory compliance and product development. With a strong market presence, Maco Pharma continues to advance the field of transfusion medicine, ensuring better patient outcomes worldwide.
DitchCarbon Score
How does Maco Pharma International GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Maco Pharma International GmbH's score of 15 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Maco Pharma International GmbH's reported carbon emissions
Maco Pharma International GmbH, headquartered in Germany, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and reducing their carbon footprints. Maco Pharma may be engaging in similar initiatives, although specific details are not available at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Maco Pharma International GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
